Discovery of a Carbamoyl Phosphate Synthetase 1–Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis
Tong Wu(Second Military Medical University), Lei Chen(Shanghai Third People's Hospital), Jin Gu(Tsinghua University), Chengjun Sui(Second Military Medical University), Ji Hu(ShanghaiTech University), Bo Zheng(Suzhou Municipal Hospital), Jing Tang(Union Hospital), Xinyao Qiu(Hainan Tropical Ocean University), Yan Zhao(Wuhan University), Yangqianwen Zhang(Second Military Medical University), Guijuan Luo(Second Military Medical University), Jianmin Wu(Fudan University), Jinxia Bao(Second Military Medical University), Qiuyu Lian(Shanghai Jiao Tong University), Siyun Shen(Second Military Medical University), Kaiting Wang(Qilu Hospital of Shandong University), Wenwen Wang(Research Center for Eco-Environmental Sciences), Yang Zhao(Beijing Proteome Research Center), Hongyang Wang(Second Military Medical University), Zhixuan Li(Sun Yat-sen University), Yanjing Zhu(Shanghai Medical College of Fudan University), Shan Wang(Island Hospital), Xuan Wu(Sichuan University), Yani Zhang(University of Science and Technology of China), Shuai Yang(Second Military Medical University)
Cited by 65
Related Papers
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
|Nature Communications|2018|1k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing
|Cell Discovery|2020|786
Comprehensive analysis of spatial architecture in primary liver cancer
|Science Advances|2021|359